Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TRMT10B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF213 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MGC45922 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC8A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM208B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR4657 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMKMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAUS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGFBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC63 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on